Metabolic disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients who schedule to undergo painless gastroenteroscopy; (2)18-65 years old, regardless of gender; (3)ASA Class?-?; (4)BMI18-30 kg/m2; (5)Informed consent, voluntarily participate in the trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1)Patients with severe heart, brain, lung, liver, kidney and metabolic diseases; (2)Patients with previous history of gastrointestinal surgery or gastrointestinal diversion surgery; (3)ECG showed that the heart rate was 180mmHg and/or diastolic blood pressure>110mmHg in patients with hypertension, or <90/60mmHg in patients with hypotension before examination; (5)Subjects have severe communication disorders caused by severe hearing deterioration; (6)Women during pregnancy, lactation and menstruation; (7)Diabetes with unstable blood sugar and diabetes related complications; (8)Patients with suspected gastroesophageal reflux disease, achalasia, severe eating and drinking disorders; (9)Recent use of drugs affecting gastric emptying; (10)Subjects who are not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastric residual volume; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative blood glucose;Patient comfort (thirst, hunger, dry lips, nausea, vomiting, abdominal distension, abdominal pain, belching) ;Vital signs;Safety evaluation; | — |
Countries
China
Contacts
Affiliated Hospital of Xuzhou Medical University